nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocodone—CYP2D6—Fingolimod—multiple sclerosis	0.157	0.261	CbGbCtD
Hydrocodone—CYP3A4—Fingolimod—multiple sclerosis	0.0996	0.166	CbGbCtD
Hydrocodone—CYP3A4—Methylprednisolone—multiple sclerosis	0.0642	0.107	CbGbCtD
Hydrocodone—CYP3A4—Triamcinolone—multiple sclerosis	0.0487	0.081	CbGbCtD
Hydrocodone—CYP3A4—Mitoxantrone—multiple sclerosis	0.0468	0.078	CbGbCtD
Hydrocodone—CYP3A4—Betamethasone—multiple sclerosis	0.0417	0.0695	CbGbCtD
Hydrocodone—CYP3A4—Prednisolone—multiple sclerosis	0.0412	0.0686	CbGbCtD
Hydrocodone—CYP3A4—Prednisone—multiple sclerosis	0.0389	0.0648	CbGbCtD
Hydrocodone—CYP2D6—Dexamethasone—multiple sclerosis	0.0382	0.0636	CbGbCtD
Hydrocodone—CYP3A4—Dexamethasone—multiple sclerosis	0.0243	0.0404	CbGbCtD
Hydrocodone—Naloxone—TLR4—multiple sclerosis	0.00544	0.708	CrCbGaD
Hydrocodone—Galantamine—BCHE—multiple sclerosis	0.00157	0.204	CrCbGaD
Hydrocodone—OPRM1—nerve—multiple sclerosis	0.00126	0.188	CbGeAlD
Hydrocodone—Paraesthesia—Cladribine—multiple sclerosis	0.001	0.00391	CcSEcCtD
Hydrocodone—Dyspnoea—Cladribine—multiple sclerosis	0.000994	0.00388	CcSEcCtD
Hydrocodone—Somnolence—Cladribine—multiple sclerosis	0.000991	0.00387	CcSEcCtD
Hydrocodone—Mood swings—Dexamethasone—multiple sclerosis	0.000967	0.00377	CcSEcCtD
Hydrocodone—Mood swings—Betamethasone—multiple sclerosis	0.000967	0.00377	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000963	0.00376	CcSEcCtD
Hydrocodone—Fatigue—Cladribine—multiple sclerosis	0.000961	0.00375	CcSEcCtD
Hydrocodone—Constipation—Cladribine—multiple sclerosis	0.000954	0.00372	CcSEcCtD
Hydrocodone—Arthralgia—Azathioprine—multiple sclerosis	0.000946	0.00369	CcSEcCtD
Hydrocodone—Myalgia—Azathioprine—multiple sclerosis	0.000946	0.00369	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.000939	0.00367	CcSEcCtD
Hydrocodone—Hypokalaemia—Dexamethasone—multiple sclerosis	0.000929	0.00363	CcSEcCtD
Hydrocodone—Hypokalaemia—Betamethasone—multiple sclerosis	0.000929	0.00363	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Cladribine—multiple sclerosis	0.000912	0.00356	CcSEcCtD
Hydrocodone—Lethargy—Prednisone—multiple sclerosis	0.000907	0.00354	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Triamcinolone—multiple sclerosis	0.000904	0.00353	CcSEcCtD
Hydrocodone—Osteoarthritis—Prednisone—multiple sclerosis	0.000889	0.00347	CcSEcCtD
Hydrocodone—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000888	0.00346	CcSEcCtD
Hydrocodone—Abdominal pain—Cladribine—multiple sclerosis	0.000882	0.00344	CcSEcCtD
Hydrocodone—Body temperature increased—Cladribine—multiple sclerosis	0.000882	0.00344	CcSEcCtD
Hydrocodone—Skin disorder—Azathioprine—multiple sclerosis	0.000881	0.00344	CcSEcCtD
Hydrocodone—Affect lability—Prednisone—multiple sclerosis	0.000875	0.00341	CcSEcCtD
Hydrocodone—Back pain—Mitoxantrone—multiple sclerosis	0.000869	0.00339	CcSEcCtD
Hydrocodone—Hypotension—Azathioprine—multiple sclerosis	0.000847	0.00331	CcSEcCtD
Hydrocodone—Mood swings—Prednisone—multiple sclerosis	0.000842	0.00329	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.000826	0.00322	CcSEcCtD
Hydrocodone—Hypersensitivity—Cladribine—multiple sclerosis	0.000822	0.00321	CcSEcCtD
Hydrocodone—Hypokalaemia—Prednisone—multiple sclerosis	0.000809	0.00316	CcSEcCtD
Hydrocodone—Asthenia—Cladribine—multiple sclerosis	0.0008	0.00312	CcSEcCtD
Hydrocodone—Pruritus—Cladribine—multiple sclerosis	0.000789	0.00308	CcSEcCtD
Hydrocodone—Cough—Mitoxantrone—multiple sclerosis	0.000784	0.00306	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000783	0.00305	CcSEcCtD
Hydrocodone—Convulsion—Mitoxantrone—multiple sclerosis	0.000778	0.00304	CcSEcCtD
Hydrocodone—Arthralgia—Mitoxantrone—multiple sclerosis	0.000765	0.00298	CcSEcCtD
Hydrocodone—Myalgia—Mitoxantrone—multiple sclerosis	0.000765	0.00298	CcSEcCtD
Hydrocodone—Connective tissue disorder—Methylprednisolone—multiple sclerosis	0.000763	0.00298	CcSEcCtD
Hydrocodone—Anxiety—Mitoxantrone—multiple sclerosis	0.000762	0.00297	CcSEcCtD
Hydrocodone—Lethargy—Methotrexate—multiple sclerosis	0.000758	0.00296	CcSEcCtD
Hydrocodone—Osteoarthritis—Methotrexate—multiple sclerosis	0.000743	0.0029	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000741	0.00289	CcSEcCtD
Hydrocodone—Dizziness—Cladribine—multiple sclerosis	0.000737	0.00288	CcSEcCtD
Hydrocodone—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000718	0.0028	CcSEcCtD
Hydrocodone—Abdominal pain—Azathioprine—multiple sclerosis	0.000717	0.0028	CcSEcCtD
Hydrocodone—Body temperature increased—Azathioprine—multiple sclerosis	0.000717	0.0028	CcSEcCtD
Hydrocodone—Skin disorder—Mitoxantrone—multiple sclerosis	0.000712	0.00278	CcSEcCtD
Hydrocodone—Vomiting—Cladribine—multiple sclerosis	0.000709	0.00277	CcSEcCtD
Hydrocodone—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000709	0.00277	CcSEcCtD
Hydrocodone—Angiopathy—Methylprednisolone—multiple sclerosis	0.000705	0.00275	CcSEcCtD
Hydrocodone—Mood swings—Methotrexate—multiple sclerosis	0.000704	0.00275	CcSEcCtD
Hydrocodone—Rash—Cladribine—multiple sclerosis	0.000703	0.00274	CcSEcCtD
Hydrocodone—Dermatitis—Cladribine—multiple sclerosis	0.000702	0.00274	CcSEcCtD
Hydrocodone—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.0007	0.00273	CcSEcCtD
Hydrocodone—Headache—Cladribine—multiple sclerosis	0.000699	0.00273	CcSEcCtD
Hydrocodone—Hypotension—Mitoxantrone—multiple sclerosis	0.000685	0.00267	CcSEcCtD
Hydrocodone—Mental disorder—Methylprednisolone—multiple sclerosis	0.00068	0.00266	CcSEcCtD
Hydrocodone—Naloxone—ALB—multiple sclerosis	0.000679	0.0884	CrCbGaD
Hydrocodone—Malnutrition—Methylprednisolone—multiple sclerosis	0.000676	0.00264	CcSEcCtD
Hydrocodone—Hypersensitivity—Azathioprine—multiple sclerosis	0.000668	0.00261	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000668	0.00261	CcSEcCtD
Hydrocodone—Nausea—Cladribine—multiple sclerosis	0.000662	0.00258	CcSEcCtD
Hydrocodone—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000658	0.00257	CcSEcCtD
Hydrocodone—Back pain—Triamcinolone—multiple sclerosis	0.000655	0.00256	CcSEcCtD
Hydrocodone—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000653	0.00255	CcSEcCtD
Hydrocodone—Somnolence—Mitoxantrone—multiple sclerosis	0.000652	0.00254	CcSEcCtD
Hydrocodone—Angiopathy—Betamethasone—multiple sclerosis	0.000641	0.0025	CcSEcCtD
Hydrocodone—Angiopathy—Dexamethasone—multiple sclerosis	0.000641	0.0025	CcSEcCtD
Hydrocodone—Convulsion—Prednisolone—multiple sclerosis	0.000638	0.00249	CcSEcCtD
Hydrocodone—Fatigue—Mitoxantrone—multiple sclerosis	0.000632	0.00247	CcSEcCtD
Hydrocodone—Constipation—Mitoxantrone—multiple sclerosis	0.000627	0.00245	CcSEcCtD
Hydrocodone—Abdominal discomfort—Methotrexate—multiple sclerosis	0.000616	0.0024	CcSEcCtD
Hydrocodone—Connective tissue disorder—Prednisone—multiple sclerosis	0.000604	0.00236	CcSEcCtD
Hydrocodone—Dizziness—Azathioprine—multiple sclerosis	0.0006	0.00234	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000599	0.00234	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.000597	0.00233	CcSEcCtD
Hydrocodone—Cough—Triamcinolone—multiple sclerosis	0.000591	0.00231	CcSEcCtD
Hydrocodone—Convulsion—Triamcinolone—multiple sclerosis	0.000587	0.00229	CcSEcCtD
Hydrocodone—Convulsion—Methylprednisolone—multiple sclerosis	0.000586	0.00229	CcSEcCtD
Hydrocodone—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000581	0.00227	CcSEcCtD
Hydrocodone—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000579	0.00226	CcSEcCtD
Hydrocodone—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000579	0.00226	CcSEcCtD
Hydrocodone—Myalgia—Triamcinolone—multiple sclerosis	0.000577	0.00225	CcSEcCtD
Hydrocodone—Vomiting—Azathioprine—multiple sclerosis	0.000577	0.00225	CcSEcCtD
Hydrocodone—Arthralgia—Methylprednisolone—multiple sclerosis	0.000576	0.00225	CcSEcCtD
Hydrocodone—Myalgia—Methylprednisolone—multiple sclerosis	0.000576	0.00225	CcSEcCtD
Hydrocodone—Anxiety—Methylprednisolone—multiple sclerosis	0.000574	0.00224	CcSEcCtD
Hydrocodone—Drowsiness—Methotrexate—multiple sclerosis	0.000573	0.00223	CcSEcCtD
Hydrocodone—Rash—Azathioprine—multiple sclerosis	0.000572	0.00223	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000572	0.00223	CcSEcCtD
Hydrocodone—Dermatitis—Azathioprine—multiple sclerosis	0.000571	0.00223	CcSEcCtD
Hydrocodone—Headache—Azathioprine—multiple sclerosis	0.000568	0.00222	CcSEcCtD
Hydrocodone—Dry mouth—Triamcinolone—multiple sclerosis	0.000564	0.0022	CcSEcCtD
Hydrocodone—Angiopathy—Prednisone—multiple sclerosis	0.000558	0.00218	CcSEcCtD
Hydrocodone—Insomnia—Prednisolone—multiple sclerosis	0.000544	0.00212	CcSEcCtD
Hydrocodone—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000541	0.00211	CcSEcCtD
Hydrocodone—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00054	0.00211	CcSEcCtD
Hydrocodone—Paraesthesia—Prednisolone—multiple sclerosis	0.00054	0.00211	CcSEcCtD
Hydrocodone—OPRM1—brainstem—multiple sclerosis	0.000539	0.0806	CbGeAlD
Hydrocodone—Mental disorder—Prednisone—multiple sclerosis	0.000539	0.0021	CcSEcCtD
Hydrocodone—Nausea—Azathioprine—multiple sclerosis	0.000539	0.0021	CcSEcCtD
Hydrocodone—Skin disorder—Methylprednisolone—multiple sclerosis	0.000536	0.00209	CcSEcCtD
Hydrocodone—Malnutrition—Prednisone—multiple sclerosis	0.000535	0.00209	CcSEcCtD
Hydrocodone—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000535	0.00209	CcSEcCtD
Hydrocodone—Agranulocytosis—Methotrexate—multiple sclerosis	0.000534	0.00209	CcSEcCtD
Hydrocodone—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000533	0.00208	CcSEcCtD
Hydrocodone—Convulsion—Dexamethasone—multiple sclerosis	0.000533	0.00208	CcSEcCtD
Hydrocodone—Convulsion—Betamethasone—multiple sclerosis	0.000533	0.00208	CcSEcCtD
Hydrocodone—Asthenia—Mitoxantrone—multiple sclerosis	0.000526	0.00205	CcSEcCtD
Hydrocodone—Myalgia—Betamethasone—multiple sclerosis	0.000523	0.00204	CcSEcCtD
Hydrocodone—Myalgia—Dexamethasone—multiple sclerosis	0.000523	0.00204	CcSEcCtD
Hydrocodone—Anxiety—Betamethasone—multiple sclerosis	0.000522	0.00204	CcSEcCtD
Hydrocodone—Anxiety—Dexamethasone—multiple sclerosis	0.000522	0.00204	CcSEcCtD
Hydrocodone—Hypotension—Methylprednisolone—multiple sclerosis	0.000516	0.00201	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000504	0.00197	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000503	0.00196	CcSEcCtD
Hydrocodone—Insomnia—Triamcinolone—multiple sclerosis	0.0005	0.00195	CcSEcCtD
Hydrocodone—Insomnia—Methylprednisolone—multiple sclerosis	0.000499	0.00195	CcSEcCtD
Hydrocodone—Paraesthesia—Triamcinolone—multiple sclerosis	0.000497	0.00194	CcSEcCtD
Hydrocodone—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000495	0.00193	CcSEcCtD
Hydrocodone—Dyspnoea—Triamcinolone—multiple sclerosis	0.000493	0.00192	CcSEcCtD
Hydrocodone—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000492	0.00192	CcSEcCtD
Hydrocodone—Nervous system disorder—Betamethasone—multiple sclerosis	0.000492	0.00192	CcSEcCtD
Hydrocodone—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000491	0.00192	CcSEcCtD
Hydrocodone—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000491	0.00192	CcSEcCtD
Hydrocodone—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000485	0.00189	CcSEcCtD
Hydrocodone—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000485	0.00189	CcSEcCtD
Hydrocodone—Fatigue—Triamcinolone—multiple sclerosis	0.000477	0.00186	CcSEcCtD
Hydrocodone—Fatigue—Methylprednisolone—multiple sclerosis	0.000476	0.00186	CcSEcCtD
Hydrocodone—Hypotension—Betamethasone—multiple sclerosis	0.000469	0.00183	CcSEcCtD
Hydrocodone—Hypotension—Dexamethasone—multiple sclerosis	0.000469	0.00183	CcSEcCtD
Hydrocodone—Angiopathy—Methotrexate—multiple sclerosis	0.000466	0.00182	CcSEcCtD
Hydrocodone—Vomiting—Mitoxantrone—multiple sclerosis	0.000466	0.00182	CcSEcCtD
Hydrocodone—Convulsion—Prednisone—multiple sclerosis	0.000464	0.00181	CcSEcCtD
Hydrocodone—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000463	0.00181	CcSEcCtD
Hydrocodone—Rash—Mitoxantrone—multiple sclerosis	0.000462	0.0018	CcSEcCtD
Hydrocodone—Dermatitis—Mitoxantrone—multiple sclerosis	0.000462	0.0018	CcSEcCtD
Hydrocodone—Headache—Mitoxantrone—multiple sclerosis	0.000459	0.00179	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000457	0.00178	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000457	0.00178	CcSEcCtD
Hydrocodone—Myalgia—Prednisone—multiple sclerosis	0.000456	0.00178	CcSEcCtD
Hydrocodone—Arthralgia—Prednisone—multiple sclerosis	0.000456	0.00178	CcSEcCtD
Hydrocodone—Anxiety—Prednisone—multiple sclerosis	0.000454	0.00177	CcSEcCtD
Hydrocodone—Insomnia—Betamethasone—multiple sclerosis	0.000454	0.00177	CcSEcCtD
Hydrocodone—Insomnia—Dexamethasone—multiple sclerosis	0.000454	0.00177	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000453	0.00177	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000451	0.00176	CcSEcCtD
Hydrocodone—Paraesthesia—Dexamethasone—multiple sclerosis	0.000451	0.00176	CcSEcCtD
Hydrocodone—Paraesthesia—Betamethasone—multiple sclerosis	0.000451	0.00176	CcSEcCtD
Hydrocodone—Mental disorder—Methotrexate—multiple sclerosis	0.00045	0.00176	CcSEcCtD
Hydrocodone—Malnutrition—Methotrexate—multiple sclerosis	0.000447	0.00175	CcSEcCtD
Hydrocodone—Hypersensitivity—Prednisolone—multiple sclerosis	0.000443	0.00173	CcSEcCtD
Hydrocodone—Body temperature increased—Triamcinolone—multiple sclerosis	0.000437	0.00171	CcSEcCtD
Hydrocodone—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000436	0.0017	CcSEcCtD
Hydrocodone—Nausea—Mitoxantrone—multiple sclerosis	0.000435	0.0017	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000433	0.00169	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000433	0.00169	CcSEcCtD
Hydrocodone—Back pain—Methotrexate—multiple sclerosis	0.000433	0.00169	CcSEcCtD
Hydrocodone—Fatigue—Betamethasone—multiple sclerosis	0.000433	0.00169	CcSEcCtD
Hydrocodone—Fatigue—Dexamethasone—multiple sclerosis	0.000433	0.00169	CcSEcCtD
Hydrocodone—Nervous system disorder—Prednisone—multiple sclerosis	0.000429	0.00167	CcSEcCtD
Hydrocodone—Skin disorder—Prednisone—multiple sclerosis	0.000424	0.00166	CcSEcCtD
Hydrocodone—Hyperhidrosis—Prednisone—multiple sclerosis	0.000422	0.00165	CcSEcCtD
Hydrocodone—OPRD1—nervous system—multiple sclerosis	0.000414	0.0619	CbGeAlD
Hydrocodone—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.00041	0.0016	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.00041	0.0016	CcSEcCtD
Hydrocodone—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000407	0.00159	CcSEcCtD
Hydrocodone—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000407	0.00159	CcSEcCtD
Hydrocodone—OPRD1—central nervous system—multiple sclerosis	0.000399	0.0596	CbGeAlD
Hydrocodone—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000398	0.00155	CcSEcCtD
Hydrocodone—Dizziness—Prednisolone—multiple sclerosis	0.000398	0.00155	CcSEcCtD
Hydrocodone—OPRK1—nervous system—multiple sclerosis	0.000397	0.0594	CbGeAlD
Hydrocodone—Asthenia—Triamcinolone—multiple sclerosis	0.000397	0.00155	CcSEcCtD
Hydrocodone—Abdominal pain—Dexamethasone—multiple sclerosis	0.000397	0.00155	CcSEcCtD
Hydrocodone—Abdominal pain—Betamethasone—multiple sclerosis	0.000397	0.00155	CcSEcCtD
Hydrocodone—Body temperature increased—Dexamethasone—multiple sclerosis	0.000397	0.00155	CcSEcCtD
Hydrocodone—Body temperature increased—Betamethasone—multiple sclerosis	0.000397	0.00155	CcSEcCtD
Hydrocodone—Asthenia—Methylprednisolone—multiple sclerosis	0.000396	0.00154	CcSEcCtD
Hydrocodone—Insomnia—Prednisone—multiple sclerosis	0.000395	0.00154	CcSEcCtD
Hydrocodone—Paraesthesia—Prednisone—multiple sclerosis	0.000392	0.00153	CcSEcCtD
Hydrocodone—Pruritus—Triamcinolone—multiple sclerosis	0.000391	0.00153	CcSEcCtD
Hydrocodone—Cough—Methotrexate—multiple sclerosis	0.00039	0.00152	CcSEcCtD
Hydrocodone—Pruritus—Methylprednisolone—multiple sclerosis	0.00039	0.00152	CcSEcCtD
Hydrocodone—Convulsion—Methotrexate—multiple sclerosis	0.000388	0.00151	CcSEcCtD
Hydrocodone—OPRK1—central nervous system—multiple sclerosis	0.000382	0.0572	CbGeAlD
Hydrocodone—Myalgia—Methotrexate—multiple sclerosis	0.000381	0.00149	CcSEcCtD
Hydrocodone—Arthralgia—Methotrexate—multiple sclerosis	0.000381	0.00149	CcSEcCtD
Hydrocodone—Rash—Prednisolone—multiple sclerosis	0.000379	0.00148	CcSEcCtD
Hydrocodone—Dermatitis—Prednisolone—multiple sclerosis	0.000379	0.00148	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000378	0.00148	CcSEcCtD
Hydrocodone—Fatigue—Prednisone—multiple sclerosis	0.000377	0.00147	CcSEcCtD
Hydrocodone—Headache—Prednisolone—multiple sclerosis	0.000377	0.00147	CcSEcCtD
Hydrocodone—OPRK1—cerebellum—multiple sclerosis	0.000374	0.0559	CbGeAlD
Hydrocodone—Constipation—Prednisone—multiple sclerosis	0.000374	0.00146	CcSEcCtD
Hydrocodone—Dizziness—Triamcinolone—multiple sclerosis	0.000366	0.00143	CcSEcCtD
Hydrocodone—Dizziness—Methylprednisolone—multiple sclerosis	0.000365	0.00142	CcSEcCtD
Hydrocodone—Asthenia—Dexamethasone—multiple sclerosis	0.00036	0.0014	CcSEcCtD
Hydrocodone—Asthenia—Betamethasone—multiple sclerosis	0.00036	0.0014	CcSEcCtD
Hydrocodone—Nervous system disorder—Methotrexate—multiple sclerosis	0.000358	0.0014	CcSEcCtD
Hydrocodone—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000358	0.0014	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000357	0.00139	CcSEcCtD
Hydrocodone—Nausea—Prednisolone—multiple sclerosis	0.000357	0.00139	CcSEcCtD
Hydrocodone—Pruritus—Dexamethasone—multiple sclerosis	0.000355	0.00139	CcSEcCtD
Hydrocodone—Pruritus—Betamethasone—multiple sclerosis	0.000355	0.00139	CcSEcCtD
Hydrocodone—Skin disorder—Methotrexate—multiple sclerosis	0.000355	0.00138	CcSEcCtD
Hydrocodone—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000353	0.00138	CcSEcCtD
Hydrocodone—Vomiting—Triamcinolone—multiple sclerosis	0.000352	0.00137	CcSEcCtD
Hydrocodone—Vomiting—Methylprednisolone—multiple sclerosis	0.000351	0.00137	CcSEcCtD
Hydrocodone—Rash—Triamcinolone—multiple sclerosis	0.000349	0.00136	CcSEcCtD
Hydrocodone—Dermatitis—Triamcinolone—multiple sclerosis	0.000348	0.00136	CcSEcCtD
Hydrocodone—Rash—Methylprednisolone—multiple sclerosis	0.000348	0.00136	CcSEcCtD
Hydrocodone—Dermatitis—Methylprednisolone—multiple sclerosis	0.000348	0.00136	CcSEcCtD
Hydrocodone—Headache—Triamcinolone—multiple sclerosis	0.000346	0.00135	CcSEcCtD
Hydrocodone—Headache—Methylprednisolone—multiple sclerosis	0.000346	0.00135	CcSEcCtD
Hydrocodone—Body temperature increased—Prednisone—multiple sclerosis	0.000345	0.00135	CcSEcCtD
Hydrocodone—Abdominal pain—Prednisone—multiple sclerosis	0.000345	0.00135	CcSEcCtD
Hydrocodone—OPRM1—midbrain—multiple sclerosis	0.000344	0.0514	CbGeAlD
Hydrocodone—Hypotension—Methotrexate—multiple sclerosis	0.000341	0.00133	CcSEcCtD
Hydrocodone—OPRM1—spinal cord—multiple sclerosis	0.000335	0.0501	CbGeAlD
Hydrocodone—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000333	0.0013	CcSEcCtD
Hydrocodone—Dizziness—Dexamethasone—multiple sclerosis	0.000332	0.00129	CcSEcCtD
Hydrocodone—Dizziness—Betamethasone—multiple sclerosis	0.000332	0.00129	CcSEcCtD
Hydrocodone—Insomnia—Methotrexate—multiple sclerosis	0.00033	0.00129	CcSEcCtD
Hydrocodone—Nausea—Triamcinolone—multiple sclerosis	0.000328	0.00128	CcSEcCtD
Hydrocodone—Paraesthesia—Methotrexate—multiple sclerosis	0.000328	0.00128	CcSEcCtD
Hydrocodone—Nausea—Methylprednisolone—multiple sclerosis	0.000328	0.00128	CcSEcCtD
Hydrocodone—Dyspnoea—Methotrexate—multiple sclerosis	0.000326	0.00127	CcSEcCtD
Hydrocodone—Somnolence—Methotrexate—multiple sclerosis	0.000325	0.00127	CcSEcCtD
Hydrocodone—Hypersensitivity—Prednisone—multiple sclerosis	0.000322	0.00126	CcSEcCtD
Hydrocodone—Vomiting—Betamethasone—multiple sclerosis	0.000319	0.00124	CcSEcCtD
Hydrocodone—Vomiting—Dexamethasone—multiple sclerosis	0.000319	0.00124	CcSEcCtD
Hydrocodone—OPRD1—brain—multiple sclerosis	0.000317	0.0474	CbGeAlD
Hydrocodone—Rash—Betamethasone—multiple sclerosis	0.000316	0.00123	CcSEcCtD
Hydrocodone—Rash—Dexamethasone—multiple sclerosis	0.000316	0.00123	CcSEcCtD
Hydrocodone—Dermatitis—Betamethasone—multiple sclerosis	0.000316	0.00123	CcSEcCtD
Hydrocodone—Dermatitis—Dexamethasone—multiple sclerosis	0.000316	0.00123	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000315	0.00123	CcSEcCtD
Hydrocodone—Fatigue—Methotrexate—multiple sclerosis	0.000315	0.00123	CcSEcCtD
Hydrocodone—Headache—Betamethasone—multiple sclerosis	0.000314	0.00123	CcSEcCtD
Hydrocodone—Headache—Dexamethasone—multiple sclerosis	0.000314	0.00123	CcSEcCtD
Hydrocodone—Asthenia—Prednisone—multiple sclerosis	0.000314	0.00122	CcSEcCtD
Hydrocodone—Pruritus—Prednisone—multiple sclerosis	0.000309	0.00121	CcSEcCtD
Hydrocodone—OPRK1—brain—multiple sclerosis	0.000304	0.0454	CbGeAlD
Hydrocodone—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000299	0.00117	CcSEcCtD
Hydrocodone—Nausea—Dexamethasone—multiple sclerosis	0.000298	0.00116	CcSEcCtD
Hydrocodone—Nausea—Betamethasone—multiple sclerosis	0.000298	0.00116	CcSEcCtD
Hydrocodone—Dizziness—Prednisone—multiple sclerosis	0.000289	0.00113	CcSEcCtD
Hydrocodone—Body temperature increased—Methotrexate—multiple sclerosis	0.000289	0.00113	CcSEcCtD
Hydrocodone—Abdominal pain—Methotrexate—multiple sclerosis	0.000289	0.00113	CcSEcCtD
Hydrocodone—OPRM1—nervous system—multiple sclerosis	0.000283	0.0423	CbGeAlD
Hydrocodone—Vomiting—Prednisone—multiple sclerosis	0.000278	0.00108	CcSEcCtD
Hydrocodone—Rash—Prednisone—multiple sclerosis	0.000276	0.00108	CcSEcCtD
Hydrocodone—Dermatitis—Prednisone—multiple sclerosis	0.000275	0.00107	CcSEcCtD
Hydrocodone—Headache—Prednisone—multiple sclerosis	0.000274	0.00107	CcSEcCtD
Hydrocodone—OPRM1—central nervous system—multiple sclerosis	0.000272	0.0407	CbGeAlD
Hydrocodone—Hypersensitivity—Methotrexate—multiple sclerosis	0.000269	0.00105	CcSEcCtD
Hydrocodone—Asthenia—Methotrexate—multiple sclerosis	0.000262	0.00102	CcSEcCtD
Hydrocodone—Nausea—Prednisone—multiple sclerosis	0.00026	0.00101	CcSEcCtD
Hydrocodone—Pruritus—Methotrexate—multiple sclerosis	0.000258	0.00101	CcSEcCtD
Hydrocodone—Dizziness—Methotrexate—multiple sclerosis	0.000241	0.000942	CcSEcCtD
Hydrocodone—Vomiting—Methotrexate—multiple sclerosis	0.000232	0.000906	CcSEcCtD
Hydrocodone—Rash—Methotrexate—multiple sclerosis	0.00023	0.000899	CcSEcCtD
Hydrocodone—Dermatitis—Methotrexate—multiple sclerosis	0.00023	0.000898	CcSEcCtD
Hydrocodone—Headache—Methotrexate—multiple sclerosis	0.000229	0.000893	CcSEcCtD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.000222	0.00172	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—RGS1—multiple sclerosis	0.000221	0.00172	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—S1PR1—multiple sclerosis	0.00022	0.00171	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—CXCL13—multiple sclerosis	0.000219	0.0017	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—CCR1—multiple sclerosis	0.000219	0.0017	CbGpPWpGaD
Hydrocodone—Nausea—Methotrexate—multiple sclerosis	0.000217	0.000846	CcSEcCtD
Hydrocodone—OPRM1—GPCR ligand binding—PTGER4—multiple sclerosis	0.000217	0.00168	CbGpPWpGaD
Hydrocodone—OPRM1—G alpha (i) signalling events—CCR5—multiple sclerosis	0.000217	0.00168	CbGpPWpGaD
Hydrocodone—CYP2D6—brainstem—multiple sclerosis	0.000216	0.0323	CbGeAlD
Hydrocodone—OPRM1—brain—multiple sclerosis	0.000216	0.0323	CbGeAlD
Hydrocodone—OPRK1—GPCR downstream signaling—CCR1—multiple sclerosis	0.000211	0.00164	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000211	0.00164	CbGpPWpGaD
Hydrocodone—OPRM1—TCR Signaling Pathway—TGFB1—multiple sclerosis	0.000211	0.00163	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—GPR65—multiple sclerosis	0.00021	0.00163	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—CXCR3—multiple sclerosis	0.000209	0.00162	CbGpPWpGaD
Hydrocodone—OPRM1—TCR Signaling Pathway—MAPK1—multiple sclerosis	0.000206	0.0016	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—RGS1—multiple sclerosis	0.000206	0.0016	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000204	0.00158	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—CCR2—multiple sclerosis	0.000204	0.00158	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—LINGO1—multiple sclerosis	0.000203	0.00157	CbGpPWpGaD
Hydrocodone—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000201	0.00156	CbGpPWpGaD
Hydrocodone—OPRM1—Peptide ligand-binding receptors—POMC—multiple sclerosis	0.000201	0.00156	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—TAGAP—multiple sclerosis	0.000201	0.00156	CbGpPWpGaD
Hydrocodone—OPRK1—G alpha (i) signalling events—POMC—multiple sclerosis	0.0002	0.00155	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—CXCL10—multiple sclerosis	0.0002	0.00155	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—CCL5—multiple sclerosis	0.000197	0.00152	CbGpPWpGaD
Hydrocodone—OPRM1—Peptide ligand-binding receptors—CCL2—multiple sclerosis	0.000197	0.00152	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—GPR65—multiple sclerosis	0.000195	0.00151	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—CCR1—multiple sclerosis	0.000192	0.00149	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—CXCL13—multiple sclerosis	0.000192	0.00149	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000191	0.00148	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—CNR1—multiple sclerosis	0.000188	0.00146	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—RGS1—multiple sclerosis	0.000187	0.00145	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000182	0.00141	CbGpPWpGaD
Hydrocodone—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000181	0.0014	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000179	0.00139	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—CCR1—multiple sclerosis	0.000179	0.00139	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000178	0.00138	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—GPR65—multiple sclerosis	0.000177	0.00138	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—CCR5—multiple sclerosis	0.000177	0.00137	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TAGAP—multiple sclerosis	0.000176	0.00136	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—S1PR1—multiple sclerosis	0.000175	0.00136	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—CCL5—multiple sclerosis	0.000172	0.00134	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000172	0.00134	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—LINGO1—multiple sclerosis	0.000172	0.00133	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—GPC5—multiple sclerosis	0.000171	0.00132	CbGpPWpGaD
Hydrocodone—OPRM1—G alpha (i) signalling events—POMC—multiple sclerosis	0.000169	0.00131	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—CXCL10—multiple sclerosis	0.000169	0.00131	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000165	0.00128	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CXCL13—multiple sclerosis	0.000162	0.00126	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CCR1—multiple sclerosis	0.000162	0.00126	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.00016	0.00124	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000159	0.00124	CbGpPWpGaD
Hydrocodone—OPRM1—TCR Signaling Pathway—IL6—multiple sclerosis	0.000159	0.00123	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—CCL3—multiple sclerosis	0.000156	0.00121	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000156	0.00121	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000155	0.0012	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—CCR5—multiple sclerosis	0.000155	0.0012	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—S1PR1—multiple sclerosis	0.000154	0.00119	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—PTGER4—multiple sclerosis	0.00015	0.00116	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—GPC5—multiple sclerosis	0.00015	0.00116	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—RGS1—multiple sclerosis	0.000149	0.00116	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TAGAP—multiple sclerosis	0.000149	0.00115	CbGpPWpGaD
Hydrocodone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000146	0.00113	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—CCL5—multiple sclerosis	0.000146	0.00113	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000145	0.00112	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000145	0.00112	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000143	0.00111	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—GPR65—multiple sclerosis	0.000141	0.0011	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—CCR2—multiple sclerosis	0.000141	0.00109	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.00014	0.00109	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—POMC—multiple sclerosis	0.000138	0.00107	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—CCL3—multiple sclerosis	0.000137	0.00106	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000136	0.00106	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—CCL2—multiple sclerosis	0.000135	0.00105	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000135	0.00104	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000132	0.00102	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000132	0.00102	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—CCR5—multiple sclerosis	0.000131	0.00102	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—RGS1—multiple sclerosis	0.000131	0.00101	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—CNR1—multiple sclerosis	0.00013	0.00101	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—S1PR1—multiple sclerosis	0.00013	0.00101	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CCR1—multiple sclerosis	0.000129	0.001	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CXCL13—multiple sclerosis	0.000129	0.001	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000129	0.001	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000127	0.000986	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—GPC5—multiple sclerosis	0.000126	0.000981	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000126	0.000975	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—GPR65—multiple sclerosis	0.000124	0.000961	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—CCR2—multiple sclerosis	0.000124	0.000959	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000123	0.00095	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—POMC—multiple sclerosis	0.000121	0.000941	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—CCL2—multiple sclerosis	0.000119	0.000921	CbGpPWpGaD
Hydrocodone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000118	0.000918	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000118	0.000918	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000117	0.000909	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CCL3—multiple sclerosis	0.000116	0.000896	CbGpPWpGaD
Hydrocodone—CYP3A4—nervous system—multiple sclerosis	0.000115	0.0172	CbGeAlD
Hydrocodone—OPRM1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000115	0.000893	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—CNR1—multiple sclerosis	0.000114	0.000885	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CCR1—multiple sclerosis	0.000113	0.000879	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CXCL13—multiple sclerosis	0.000113	0.000879	CbGpPWpGaD
Hydrocodone—CYP2D6—nervous system—multiple sclerosis	0.000113	0.0169	CbGeAlD
Hydrocodone—OPRK1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000113	0.000878	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000111	0.000863	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000111	0.000862	CbGpPWpGaD
Hydrocodone—CYP3A4—central nervous system—multiple sclerosis	0.000111	0.0166	CbGeAlD
Hydrocodone—OPRM1—Signaling Pathways—RGS1—multiple sclerosis	0.000111	0.000857	CbGpPWpGaD
Hydrocodone—CYP2D6—central nervous system—multiple sclerosis	0.000109	0.0163	CbGeAlD
Hydrocodone—OPRM1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000107	0.000833	CbGpPWpGaD
Hydrocodone—CYP2D6—cerebellum—multiple sclerosis	0.000107	0.0159	CbGeAlD
Hydrocodone—OPRM1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000106	0.000824	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—GPR65—multiple sclerosis	0.000105	0.000813	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CCR2—multiple sclerosis	0.000105	0.000811	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—SRM—multiple sclerosis	0.000104	0.000805	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000103	0.000797	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—POMC—multiple sclerosis	0.000103	0.000796	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—CCL5—multiple sclerosis	0.000101	0.000782	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—CCL2—multiple sclerosis	0.0001	0.000778	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—CCR5—multiple sclerosis	0.0001	0.000776	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—IL2RA—multiple sclerosis	9.87e-05	0.000765	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—CCL5—multiple sclerosis	9.74e-05	0.000756	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CNR1—multiple sclerosis	9.65e-05	0.000748	CbGpPWpGaD
Hydrocodone—CYP2D6—Biological oxidations—POMC—multiple sclerosis	9.61e-05	0.000746	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CCR1—multiple sclerosis	9.58e-05	0.000743	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CXCL13—multiple sclerosis	9.58e-05	0.000743	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—CXCL10—multiple sclerosis	9.57e-05	0.000742	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CCL3—multiple sclerosis	9.21e-05	0.000715	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—CCR5—multiple sclerosis	9.09e-05	0.000705	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—IL2RA—multiple sclerosis	8.96e-05	0.000695	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PTGER4—multiple sclerosis	8.87e-05	0.000688	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—CCL5—multiple sclerosis	8.85e-05	0.000686	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—CCR5—multiple sclerosis	8.78e-05	0.000681	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PGR—multiple sclerosis	8.73e-05	0.000677	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CXCL10—multiple sclerosis	8.69e-05	0.000674	CbGpPWpGaD
Hydrocodone—CYP2D6—brain—multiple sclerosis	8.66e-05	0.0129	CbGeAlD
Hydrocodone—OPRK1—GPCR downstream signaling—IL2RA—multiple sclerosis	8.65e-05	0.000671	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CXCR3—multiple sclerosis	8.57e-05	0.000664	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CD28—multiple sclerosis	8.49e-05	0.000658	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CCR2—multiple sclerosis	8.33e-05	0.000646	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—CCL5—multiple sclerosis	8.23e-05	0.000639	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CCL3—multiple sclerosis	8.08e-05	0.000627	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—CCR5—multiple sclerosis	7.97e-05	0.000618	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—IL2RA—multiple sclerosis	7.86e-05	0.000609	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—POMC—multiple sclerosis	7.82e-05	0.000607	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PTGER4—multiple sclerosis	7.78e-05	0.000603	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CNR1—multiple sclerosis	7.69e-05	0.000596	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PGR—multiple sclerosis	7.66e-05	0.000594	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CXCR3—multiple sclerosis	7.51e-05	0.000582	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CCL5—multiple sclerosis	7.48e-05	0.00058	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CD28—multiple sclerosis	7.44e-05	0.000577	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—CCR5—multiple sclerosis	7.42e-05	0.000575	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—IL2RA—multiple sclerosis	7.31e-05	0.000567	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	7.31e-05	0.000567	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	7.31e-05	0.000567	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CCR2—multiple sclerosis	7.31e-05	0.000567	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—POMC—multiple sclerosis	7.1e-05	0.000551	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—CCL2—multiple sclerosis	6.95e-05	0.000539	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CXCL10—multiple sclerosis	6.92e-05	0.000537	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—POMC—multiple sclerosis	6.86e-05	0.000532	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CCL3—multiple sclerosis	6.83e-05	0.00053	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SRM—multiple sclerosis	6.78e-05	0.000526	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CNR1—multiple sclerosis	6.74e-05	0.000523	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CCR5—multiple sclerosis	6.74e-05	0.000522	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GPC5—multiple sclerosis	6.69e-05	0.000518	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—IL2RA—multiple sclerosis	6.64e-05	0.000515	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PTGER4—multiple sclerosis	6.57e-05	0.00051	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PGR—multiple sclerosis	6.47e-05	0.000502	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CXCR3—multiple sclerosis	6.35e-05	0.000492	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—TYK2—multiple sclerosis	6.31e-05	0.000489	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CD28—multiple sclerosis	6.29e-05	0.000488	CbGpPWpGaD
Hydrocodone—CYP3A4—Biological oxidations—POMC—multiple sclerosis	6.29e-05	0.000487	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—POMC—multiple sclerosis	6.23e-05	0.000483	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CCR2—multiple sclerosis	6.18e-05	0.000479	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—CCL2—multiple sclerosis	6.1e-05	0.000473	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CXCL10—multiple sclerosis	6.07e-05	0.000471	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CD86—multiple sclerosis	6.05e-05	0.00047	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CCL5—multiple sclerosis	5.96e-05	0.000462	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—POMC—multiple sclerosis	5.8e-05	0.00045	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—IL2—multiple sclerosis	5.78e-05	0.000448	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CNR1—multiple sclerosis	5.7e-05	0.000442	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—RRM1—multiple sclerosis	5.54e-05	0.00043	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—TYK2—multiple sclerosis	5.53e-05	0.000429	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—SPP1—multiple sclerosis	5.52e-05	0.000428	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CCR5—multiple sclerosis	5.37e-05	0.000416	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CD86—multiple sclerosis	5.31e-05	0.000412	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IL2RA—multiple sclerosis	5.29e-05	0.00041	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—POMC—multiple sclerosis	5.26e-05	0.000408	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—IL2—multiple sclerosis	5.25e-05	0.000407	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CCL5—multiple sclerosis	5.23e-05	0.000405	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CCL2—multiple sclerosis	5.15e-05	0.000399	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CXCL10—multiple sclerosis	5.13e-05	0.000398	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—IL2—multiple sclerosis	5.07e-05	0.000393	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—APOE—multiple sclerosis	4.89e-05	0.000379	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—SPP1—multiple sclerosis	4.84e-05	0.000375	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	4.78e-05	0.000371	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	4.78e-05	0.000371	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CCR5—multiple sclerosis	4.71e-05	0.000365	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—TYK2—multiple sclerosis	4.68e-05	0.000363	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IL2RA—multiple sclerosis	4.64e-05	0.00036	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—IL2—multiple sclerosis	4.61e-05	0.000357	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CD86—multiple sclerosis	4.49e-05	0.000348	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CCL5—multiple sclerosis	4.42e-05	0.000343	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CD80—multiple sclerosis	4.42e-05	0.000343	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GPC5—multiple sclerosis	4.37e-05	0.000339	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—IL2—multiple sclerosis	4.29e-05	0.000332	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—APOE—multiple sclerosis	4.28e-05	0.000332	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—POMC—multiple sclerosis	4.2e-05	0.000325	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CCL2—multiple sclerosis	4.11e-05	0.000318	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—SPP1—multiple sclerosis	4.09e-05	0.000317	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—MAPK1—multiple sclerosis	4.02e-05	0.000312	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CCR5—multiple sclerosis	3.98e-05	0.000309	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IL2RA—multiple sclerosis	3.92e-05	0.000304	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—IL2—multiple sclerosis	3.89e-05	0.000302	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CD80—multiple sclerosis	3.87e-05	0.0003	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—TYK2—multiple sclerosis	3.73e-05	0.000289	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—POMC—multiple sclerosis	3.68e-05	0.000285	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—RRM1—multiple sclerosis	3.62e-05	0.000281	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—APOE—multiple sclerosis	3.62e-05	0.000281	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CCL2—multiple sclerosis	3.6e-05	0.000279	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—MAPK1—multiple sclerosis	3.52e-05	0.000273	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CD80—multiple sclerosis	3.27e-05	0.000254	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TYK2—multiple sclerosis	3.27e-05	0.000254	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—BCHE—multiple sclerosis	3.18e-05	0.000247	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—POMC—multiple sclerosis	3.11e-05	0.000241	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IL2—multiple sclerosis	3.1e-05	0.000241	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—IL6—multiple sclerosis	3.09e-05	0.000239	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CCL2—multiple sclerosis	3.04e-05	0.000236	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—MAPK1—multiple sclerosis	2.98e-05	0.000231	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MMP9—multiple sclerosis	2.94e-05	0.000228	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TYK2—multiple sclerosis	2.76e-05	0.000214	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IL2—multiple sclerosis	2.72e-05	0.000211	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—IL6—multiple sclerosis	2.71e-05	0.00021	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—STAT3—multiple sclerosis	2.61e-05	0.000202	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MMP9—multiple sclerosis	2.57e-05	0.0002	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MYC—multiple sclerosis	2.43e-05	0.000188	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—TGFB1—multiple sclerosis	2.42e-05	0.000188	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MAPK1—multiple sclerosis	2.37e-05	0.000184	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IL2—multiple sclerosis	2.3e-05	0.000178	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—STAT3—multiple sclerosis	2.29e-05	0.000178	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—IL6—multiple sclerosis	2.29e-05	0.000177	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MMP9—multiple sclerosis	2.18e-05	0.000169	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MYC—multiple sclerosis	2.13e-05	0.000165	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TGFB1—multiple sclerosis	2.12e-05	0.000165	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MAPK1—multiple sclerosis	2.08e-05	0.000161	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—BCHE—multiple sclerosis	2.08e-05	0.000161	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—STAT3—multiple sclerosis	1.93e-05	0.00015	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—APOE—multiple sclerosis	1.91e-05	0.000148	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IL6—multiple sclerosis	1.82e-05	0.000141	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MYC—multiple sclerosis	1.8e-05	0.000139	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TGFB1—multiple sclerosis	1.79e-05	0.000139	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MAPK1—multiple sclerosis	1.76e-05	0.000136	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—POMC—multiple sclerosis	1.64e-05	0.000128	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IL6—multiple sclerosis	1.6e-05	0.000124	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ALB—multiple sclerosis	1.5e-05	0.000116	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IL6—multiple sclerosis	1.35e-05	0.000105	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—APOE—multiple sclerosis	1.25e-05	9.7e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—POMC—multiple sclerosis	1.08e-05	8.34e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ALB—multiple sclerosis	9.8e-06	7.6e-05	CbGpPWpGaD
